Chromatin/Epigenetics
Chromatin/epigenetics inhibitors are compounds that modulate the structure and function of chromatin or interfere with epigenetic modifications, such as DNA methylation and histone modification. These inhibitors are essential tools for studying gene expression regulation and the role of epigenetics in diseases like cancer, neurological disorders, and developmental abnormalities. By targeting epigenetic processes, these inhibitors can alter gene expression patterns and offer new therapeutic avenues. At CymitQuimica, we provide a wide selection of high-quality chromatin/epigenetics inhibitors to support your research in molecular biology, genetics, and epigenetics.
Subcategories of "Chromatin/Epigenetics"
Found 2441 products of "Chromatin/Epigenetics"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
JG-2016
CAS:JG-2016, as a histone acetyltransferase 1 inhibitor, inhibits growth of human cancer cell lines and inhibits enzymatic activity in cellulose.Formula:C18H21ClN4O3Purity:99.00% - 99.37%Color and Shape:SolidMolecular weight:376.84Ref: TM-T82008
1mg116.00€5mg283.00€10mg455.00€25mg905.00€50mg1,454.00€100mg1,882.00€1mL*10mM (DMSO)310.00€AMPK activator 7
CAS:<p>AMPK activator 7 (I-3-24, EC50: 8.8 nM) targets AMPK-related disorders like type 2 diabetes and obesity.</p>Formula:C23H22F3N3O5Color and Shape:SolidMolecular weight:477.43FM-479
CAS:<p>FM-479, a structural analog of FM-381, lacks inhibition of JAK3/kinases within 100-300 nM, serving as FM-381's negative control.</p>Formula:C25H26N6O2Purity:98%Color and Shape:SolidMolecular weight:442.523AU-15330
CAS:AU-15330 is a proteolytic targeting chimera (PROTAC) that simultaneously targets SMARCA4, SMARCA2, and PBRM1 for degradation and exhibits cytotoxicity in H3.3K27M cells but not in H3 wild-type cells. Cost-effective and quality-assured.Formula:C39H49N9O5SPurity:98.21% - 99.62%Color and Shape:SolidMolecular weight:755.93EPZ031686
CAS:<p>EPZ031686 is an effective inhibitor of SMYD3 inhibitor with an IC50 of 3 nM and can be used in studies about cancer.</p>Formula:C26H34ClF3N4O4SPurity:99.67%Color and Shape:SolidMolecular weight:591.09CPI-0610 carboxylic acid
CAS:CPI-0610 carboxylic acid is a selective BET protein inhibitor with potential anticancer effects.Formula:C20H15ClN2O3Purity:98.62%Color and Shape:SolidMolecular weight:366.8LY3295668
CAS:LY3295668 (AK-01) is a selective inhibitor of Aurora A with Kis of 0.8 nM and 1038 nM for Aurora A and B, respectively.Formula:C24H26ClF2N5O2Purity:99.68%Color and Shape:SolidMolecular weight:489.95HIF-2α agonist 2
CAS:HIF-2α agonist 2 is an HIF-2α agonist with an EC50 value of 1.68 μM for HIF-2α.Formula:C13H8Br2N2O2SPurity:98.87%Color and Shape:SoildMolecular weight:416.09E7016
CAS:<p>E7016 (GPI 21016) is an orally available PARP inhibitor. E7016 inhibits of DNA repair. E7016 can enhance tumor cell radiosensitivity in vitro and in vivo.</p>Formula:C20H19N3O3Purity:99.02%Color and Shape:SolidMolecular weight:349.38JWG-071
CAS:JWG-071: First ERK5 kinase probe, BET inhibitor, 1 μM BRD4 IC, boosts ERK5 function and BRD4 selectivity.Formula:C34H44N8O3Purity:99.83%Color and Shape:SolidMolecular weight:612.77GNE-375
CAS:GNE-375 is a selective and potent BRD9 inhibitor (IC50: 5 nM).GNE-375 inhibits BRD4, TAF1, and CECR2, and can be used to study epigenetic resistance.Formula:C25H29N3O5Purity:98.99%Color and Shape:SolidMolecular weight:451.51Ref: TM-T27423
1mg117.00€5mg279.00€10mg432.00€25mg707.00€50mg1,017.00€100mg1,491.00€1mL*10mM (DMSO)315.00€CCT129202
CAS:CCT129202 is an ATP-competitive pan-Aurora inhibitor for Aurora A, Aurora B and Aurora C with IC50 of 0.042 μM, 0.198 μM and 0.227 μM, respectively.Formula:C23H25ClN8OSPurity:98.14%Color and Shape:SolidMolecular weight:497.02PARP-1-IN-4
CAS:PARP-1-IN-4 is a potent PARP-1 inhibitor with potential see anti-tumor activity, and inhibition of PARP-1 may be used in cancer development.Formula:C22H15Cl2N3O2Purity:99.82%Color and Shape:SolidMolecular weight:424.28hRIO2 kinase ligand-1
CAS:hRIO2 kinase ligand-1 is a potent ligand for hRIO2 kinase (Kd: 520 nM).Formula:C17H14N2OPurity:99.89%Color and Shape:SolidMolecular weight:262.31NPAS3-IN-1
CAS:NPAS3-IN-1 is an NPAS3-ARNT heterodimerization inhibitor that regulates NPAS3 transcription by modulating the heterodimerization of NPAS3 with ARNT.Formula:C10H5N3O2S3Purity:99.56%Color and Shape:SolidMolecular weight:295.36HS94
CAS:<p>HS94 (DAPK3 inhibitor HS94) is a selective and potent DAPK3 inhibitor with a Ki value of 126 nM for Pim kinase inhibition and can be used to study hypertension.</p>Formula:C15H15N5O2SPurity:95.04%Color and Shape:SolidMolecular weight:329.38FHT-1015
CAS:FHT-1205 is a potent inhibitor (IC50 ≤ 10 nM) of SMARCA4/SMARCA2 ATPase (BRG1 and BRM).Formula:C25H25N5O4S3Purity:98.57%Color and Shape:SolidMolecular weight:555.69Ref: TM-T63925
1mg57.00€5mg120.00€10mg188.00€25mg376.00€50mg612.00€100mg938.00€1mL*10mM (DMSO)145.00€JAK-IN-3
CAS:JAK-IN-3 is a potent JAK inhibitor that inhibits JAK3, JAK1, TYK2, and JAK2, and can be used for the study of immune system disorders.Formula:C18H20N4O3Purity:98.04% - 98.19%Color and Shape:SolidMolecular weight:340.38Ref: TM-T11704
1mg133.00€2mg188.00€5mg321.00€10mg518.00€25mg1,035.00€50mg1,644.00€100mg2,680.00€200mg3,591.00€1mL*10mM (DMSO)354.00€KDM4-IN-4
CAS:KDM4-IN-4 is a KDM4 inhibitor with anticancer activity that inhibits the KDM4A-Tudor structural domain for cancer research.Formula:C16H23NOPurity:99.61%Color and Shape:SolidMolecular weight:245.36CeMMEC1
CAS:CeMMEC1 is an inhibitor of BRD4, and also has a great affinity for TAF1(IC50=0.9 μM).Formula:C19H16N2O4Purity:98.9% - 99.92%Color and Shape:SolidMolecular weight:336.34
